488 news items
Page 4 of 25
o64cwvfk
RAPT
9 Apr 24
inhibitors, immune stimulators, cancer vaccines and adoptive T cell therapy. About RAPT Therapeutics, Inc. RAPT
styj1mnbgk3s3fvrli3kq758reghsumta
IOBT
9 Apr 24
biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, today shared new data related
4e4 whyvg2fyp
9 Apr 24
neoantigen cancer vaccine, at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA. These data
hmpw7
PFE
9 Apr 24
prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance
d2vjkmcg85qyq7e9apcsww3gzuqwgitvuz58z76ltzkyfy3vbtbgs6ha1gq
9 Apr 24
Metropolitan area as well as being home to the John Theurer Cancer Center, a premier cancer center
9tf3j1z3dkr9mklcaj3ecj8wf92e8atwsmczmqlxncj230jfmbp4wg x9mhq
9 Apr 24
vaccine in different colorectal cancer models" | Abstract 5003
84lpb8v0fciycnp60rj0024lgs4c4lqgyu7zicplkol4wlqjuvdif
XNCR
9 Apr 24
), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced
s6ss8
YS
9 Apr 24
, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced positive
p34 encpo
CLDI
9 Apr 24
mechanisms of action underlying the immunomodulatory role of Calidi's therapies at the American Association for Cancer Research Annual (AACR) Meeting 2024
r97k kv89ezj613e4ta6btkuzjr7nkb7aipnw808b8o5a5l9
9 Apr 24
cancer-specific T-cell amplifying efficacy when combined with standard of care colorectal cancer therapy
qrqhp4w
9 Apr 24
confidence in the potential for our dendritic cell vaccines to significantly improve the lives of patients with the most deadly cancers," said Mike
d152uu
8 Apr 24
therapeutic cancer vaccine, combined with LIBTAYO, an anti-PD1 checkpoint inhibitor (CPI). The data were generated in the OpcemISA trial, a large-scale
cbxo15rla2f02o vcqwgwg8rebmvnfrt850uw2dh1fmp1dgypn9gcaz8o
GRTS
8 Apr 24
on March 1, 2024. Then, on April 1, 2024, Gritstone reported mixed preliminary Phase 2 data for its personalized cancer vaccine
k0cm1mbjocjezz4o7d3m7mkvt8mxm2dbe3dyu0353
8 Apr 24
, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled "Pet Cancer Therapeutics Market Size, Trends
8bm9q1h3i9ls39dtmah5m3brvlb4p0rgn95rr23486ezy
MRK
8 Apr 24
cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales
c6it u097mqhisldlf49ogjgzuq57v8io54bhd768tenp1c
GRTS
8 Apr 24
Location: Virtual Canaccord Genuity Horizons in Oncology Virtual Conference (Panel)Panel Title: Cancer Vaccines
k13kuj1r 70r91zqf4oebz3ybp4ct4e31
SCNI
8 Apr 24
of liposomal therapeutics for the treatment of cancer and other diseases. Its flagship product, Doxorubicin HCl Liposome Injection, is FDA-approved
v3exr89ao vd
BNTX
8 Apr 24
Three-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran
4nlay3j250g648mta8et2dguv1kn8hfr8
7 Apr 24
on the development of personalized therapeutic cancer vaccines (PTCVs), today announced the publication of positive safety, immunogenicity, and efficacy data
t4cqmc142u3t3nm vu6dp
BNTX
7 Apr 24
-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran (BNT122